1. Home
  2. ACNB vs DRUG Comparison

ACNB vs DRUG Comparison

Compare ACNB & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACNB Corporation

ACNB

ACNB Corporation

HOLD

Current Price

$63.36

Market Cap

659.3M

Sector

Finance

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$80.62

Market Cap

778.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACNB
DRUG
Founded
1857
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
659.3M
778.4M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
ACNB
DRUG
Price
$63.36
$80.62
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$58.00
$129.25
AVG Volume (30 Days)
63.8K
206.5K
Earning Date
04-23-2026
05-15-2026
Dividend Yield
3.00%
N/A
EPS Growth
N/A
N/A
EPS
2.81
N/A
Revenue
$191,821,000.00
N/A
Revenue This Year
$13.18
N/A
Revenue Next Year
$1.91
N/A
P/E Ratio
$22.91
N/A
Revenue Growth
45.10
N/A
52 Week Low
$42.60
$38.00
52 Week High
$65.94
$123.75

Technical Indicators

Market Signals
Indicator
ACNB
DRUG
Relative Strength Index (RSI) 56.47 62.13
Support Level $48.10 $79.55
Resistance Level $65.94 $84.29
Average True Range (ATR) 1.50 3.71
MACD -0.11 0.73
Stochastic Oscillator 57.17 86.23

Price Performance

Historical Comparison
ACNB
DRUG

About ACNB ACNB Corporation

ACNB Corp is the financial holding company. Through its wholly-owned subsidiaries, it provides a full range of retail and commercial financial services in Pennsylvania and Maryland through its network of community banking offices. It also provides property, casualty, health, life and disability insurance serving personal and commercial clients through offices in Westminster, Maryland, and Gettysburg, Pennsylvania and is licensed to do business. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage; and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: